Rhumbline Advisers Acquires 52,630 Shares of Hill-Rom Holdings, Inc. (HRC)

Share on StockTwits

Rhumbline Advisers raised its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 40.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 183,809 shares of the medical technology company’s stock after purchasing an additional 52,630 shares during the period. Rhumbline Advisers owned approximately 0.28% of Hill-Rom worth $16,276,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. IMS Capital Management bought a new stake in Hill-Rom in the 3rd quarter valued at about $71,000. We Are One Seven LLC bought a new stake in Hill-Rom in the 4th quarter valued at about $93,000. Nkcfo LLC bought a new stake in Hill-Rom in the 4th quarter valued at about $162,000. Quantbot Technologies LP boosted its holdings in Hill-Rom by 270.2% in the 3rd quarter. Quantbot Technologies LP now owns 2,051 shares of the medical technology company’s stock valued at $193,000 after purchasing an additional 1,497 shares during the period. Finally, First Light Asset Management LLC bought a new stake in Hill-Rom in the 3rd quarter valued at about $202,000. 86.96% of the stock is owned by hedge funds and other institutional investors.

A number of analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Hill-Rom from a “hold” rating to a “sell” rating in a report on Monday, February 4th. ValuEngine raised shares of Hill-Rom from a “hold” rating to a “buy” rating in a report on Saturday, January 19th. Raymond James upped their price target on shares of Hill-Rom from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, November 5th. Finally, UBS Group assumed coverage on shares of Hill-Rom in a report on Tuesday, November 27th. They set a “buy” rating and a $115.00 price target for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $102.67.

In related news, SVP Andreas G. Frank sold 7,454 shares of the company’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $95.76, for a total transaction of $713,795.04. Following the completion of the transaction, the senior vice president now directly owns 27,224 shares in the company, valued at approximately $2,606,970.24. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.73% of the stock is owned by corporate insiders.

Shares of Hill-Rom stock opened at $102.91 on Tuesday. Hill-Rom Holdings, Inc. has a 1-year low of $79.36 and a 1-year high of $105.78. The company has a quick ratio of 1.25, a current ratio of 1.70 and a debt-to-equity ratio of 1.17. The company has a market cap of $6.84 billion, a PE ratio of 21.67, a PEG ratio of 1.45 and a beta of 0.95.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings results on Friday, January 25th. The medical technology company reported $1.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.98 by $0.04. The company had revenue of $683.50 million during the quarter, compared to the consensus estimate of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.92 EPS. On average, research analysts forecast that Hill-Rom Holdings, Inc. will post 5.06 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Rhumbline Advisers Acquires 52,630 Shares of Hill-Rom Holdings, Inc. (HRC)” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4146167/rhumbline-advisers-acquires-52630-shares-of-hill-rom-holdings-inc-hrc.html.

Hill-Rom Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: Backdoor Roth IRA

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Bausch Health Companies  Upgraded at Zacks Investment Research
Bausch Health Companies Upgraded at Zacks Investment Research
Tempur Sealy International  Downgraded by Guggenheim to “Neutral”
Tempur Sealy International Downgraded by Guggenheim to “Neutral”
Citigroup Boosts Welltower  Price Target to $75.00
Citigroup Boosts Welltower Price Target to $75.00
Deere & Company  Upgraded at Zacks Investment Research
Deere & Company Upgraded at Zacks Investment Research
Canadian Pacific Railway  Upgraded to Buy at Zacks Investment Research
Canadian Pacific Railway Upgraded to Buy at Zacks Investment Research
$2.73 Earnings Per Share Expected for SYNNEX Co.  This Quarter
$2.73 Earnings Per Share Expected for SYNNEX Co. This Quarter


Leave a Reply

© 2006-2019 Ticker Report